STMN logo

Straumann Holding AG Stock Price

SWX:STMN Community·CHF 17.0b Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 31 Fair Values set on narratives written by author

STMN Share Price Performance

CHF 106.40
1.85 (1.77%)
CHF 81.34
Fair Value
CHF 106.40
1.85 (1.77%)
30.8% overvalued intrinsic discount
CHF 81.34
Fair Value
Price CHF 106.40
AnalystLowTarget CHF 81.34
AnalystConsensusTarget CHF 108.78
AnalystHighTarget CHF 123.00

STMN Community Narratives

·
Fair Value CHF 81.34 30.8% overvalued intrinsic discount

Rising Regulation And Cost Pressures Will Curb Premium Dental Demand

0users have liked this narrative
0users have commented on this narrative
2users have followed this narrative
·
Fair Value CHF 108.78 2.2% undervalued intrinsic discount

STMN: Future Performance Will Depend On U S Operational Recovery And Margin Stability

0users have liked this narrative
0users have commented on this narrative
14users have followed this narrative
·
Fair Value CHF 123 13.5% undervalued intrinsic discount

Emerging Markets And Aging Populations Will Redefine Dental Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
CHF 81.34
30.8% overvalued intrinsic discount
Revenue
8.13% p.a.
Profit Margin
19.7%
Future PE
22.63x
Price in 2029
CHF 91.98

Trending Discussion

Updated Narratives

STMN logo

STMN: Raised Profitability Guidance And Refined Assumptions Support Balanced Forward Outlook

Fair Value: CHF 108.78 2.2% undervalued intrinsic discount
14 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
STMN logo

STMN: Rich Multiples And Execution Risks Will Likely Cap Future Returns

Fair Value: CHF 81.34 30.8% overvalued intrinsic discount
2 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative
STMN logo

STMN: Higher Future P/E Assumptions Will Support Confidence In Execution Potential

Fair Value: CHF 123 13.5% undervalued intrinsic discount
0 users have set this as their fair value
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Flawless balance sheet with reasonable growth potential.

1 Risk
2 Rewards

Straumann Holding AG Key Details

CHF 2.6b

Revenue

CHF 779.1m

Cost of Revenue

CHF 1.8b

Gross Profit

CHF 1.5b

Other Expenses

CHF 356.7m

Earnings

Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
Aug 19, 2026
2.24
70.10%
13.69%
11.5%
View Full Analysis

About STMN

Founded
1954
Employees
11570
CEO
Guillaume Daniellot
WebsiteView website
www.straumann.com

Straumann Holding AG provides tooth replacement and orthodontic solutions in Switzerland, the United States, China, Germany, Brazil, Japan, France, and internationally. It operates through Sales Europe, Middle East and Africa; Sales North America; Sales Asia Pacific; Sales Latin America; and Operations segments. The company offers dental implants, instruments, CADCAM prosthetics, orthodontic and clear aligners, biomaterials, and digital equipment and solutions for use in tooth correction, replacement, and restoration, as well as to prevent tooth loss. It also provides implant systems, components, and related instruments, as well as healing components, materials and surfaces, surgical sets and instruments, and guided surgery and navigation products; prosthetics, including angled solutions, connections, components, and molar solutions; intra-oral and lab scanners, milling machines, dynamic navigation systems, and 3D printers; consumables, such as blocks, discs, resins, titanium bases, and abutment blanks, as well as scan bodies, analogs, and sleeves; online education; and dentists and dental labs solutions. In addition, the company offers regenerative solutions for tooth preservation, implant-site management, and implant preservation; scanner hardware, software licenses, sterile-packaged products, customer training, and other products; and logistics and supply chain services. Further, it provides thermoplastics; implant treatment referral; high-tech materials; artificial intelligence solutions for dental applications; and 3D orthodontic treatment animations. The company sells its products under the Straumann, Neodent, Medentika, Anthogyr, ClearCorrect, NUVO, and other brands through a network of distribution subsidiaries and partners, and third-party distributors, as well as through its e-shop. It serves clinicals needs, patient segments, and healthcare systems. Straumann Holding AG was founded in 1954 and is headquartered in Basel, Switzerland.

Recent STMN News & Updates

Recent updates

No updates